TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novo Nordisk Pharmatech A/S
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 80,452 | 83,251 | 89,756 |
Earnings before taxes | 6,624 | 19,729 | 19,648 |
Total assets | 130,026 | 86,054 | 100,213 |
Current assets | 67,737 | 33,219 | 51,243 |
Current liabilities | 31,498 | 12,175 | 14,601 |
Equity capital | 92,737 | 69,960 | 81,517 |
- share capital | 1,345 | 1,345 | 1,344 |
Employees (average) | 150 | 150 | 150 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 71.3% | 81.3% | 81.3% |
Turnover per employee | 536 | 555 | 598 |
Profit as a percentage of turnover | 8.2% | 23.7% | 21.9% |
Return on assets (ROA) | |||
Current ratio | 215.1% | 272.8% | 351.0% |
Return on equity (ROE) | 7.1% | 28.2% | 24.1% |
Change turnover | -2,800 | -6,542 | 6,282 |
Change turnover % | -3% | -7% | 8% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.